Invigor gains data intelligence government contract
Invigor Group Limited (ASX:IVO) has secured a new contract valued at $100,000 for stage one of IPART’s data requirements for its review of the Container Deposit Scheme (CDS).
IPART is an independent pricing and regulatory tribunal, which oversees the regulation of the beverage, gas, electricity and transport industries in New South Wales.
The body will utilise IVO’s extensive data on alcoholic beverage pricing – which includes seven years of historical data – to assess the impact of the CDS on container beverage prices, the performance and conduct of suppliers and other factors which could impact consumers.
Because stage one of IPART’s analysis will be geared around historical data, the contract will generate instantaneous revenues for IVO, which is strongly positioned to clinch stages two and three of the contract moving forward.
The freshly inked contract is a significant development for the analytics solutions company, which has continued its strong track record of winning large revenue-generating data intelligence contracts.
With an exceptional pipeline of upcoming tenders mounting, IVO expects additional tender-to-contract conversions over the rest of 2018.
Of course, it should be noted that Invigor is still a speculative stock and anything can happen. Investors should seek professional financial advice if considering this stock for their portfolio.
IVO CEO Gary Cohen commented on the new contract, “Our steady growth of locking in new and larger revenue-generating data intelligence and analytics contracts with blue chip customers, recognised brands and government departments is continuing in 2018,” he said.
“It’s a pleasing contract win, and we’re delighted to be working with the NSW Government as it gives us great exposure across this large sector and positions us as a dependable and credible public sector technology provider.”
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.